Photoimmunomodulation and melatonin

Journal of Photochemistry and Photobiology B: Biology

Volumn 98, Issue 2, 2010, Pages 107-117

  Haldar, C ^a   Ahmad, R ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Immunity; Mammals; Melatonin; Melatonin receptor; Photoimmunomodulation; Seasonality

Indexed keywords

CALMODULIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; RETINOIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTHRITIS; BREAST CANCER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; DRUG RECEPTOR BINDING; EVENING DOSAGE; HUMAN; HYPOPHYSIS PARS TUBERALIS; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; ISCHEMIA; LUNG METASTASIS; NEUROENDOCRINE SYSTEM; NONHUMAN; PHOTOPERIODICITY; PHOTOSTIMULATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETINA GANGLION CELL; REVIEW; SEASONAL VARIATION; SUPRACHIASMATIC NUCLEUS; TISSUE DISTRIBUTION; ULTRAVIOLET RADIATION;

ANIMALS; CYTOKINES; HUMANS; IMMUNOMODULATION; MELATONIN; PHOTOPERIOD; RECEPTORS, MELATONIN;

MAMMALIA; RODENTIA;

EID: 75149186866     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.11.014     Document Type: Review

References (171)

1. Haldar C., and Saxena N. Pineal and humidity effect on testicular function of Indian palm squirrel F. pennanti. J. Pineal Res. 5 (1988) 411-418
2. Nelson R.J., and Drazen D.L. Melatonin mediates seasonal adjustments in immune function. Reprod. Nutr. Dev. 39 (1999) 383-398
3. Goldman B.D. Mammalian photoperiodic system: formal properties and neuroendocrine mechanisms of photoperiodic time measurement. J. Biol. Rhythms 16 (2001) 283-301
4. Maestroni G.J.M., and Conti A. Melatonin and immune-hematopoietic system. Therapeutic and adverse pharmacological correlates. Neuroimmunomodulation 3 (1996) 325-332
5. Janeway C.A., Travers P., Walport M., and Schlomchick M. Immunobiology: The Immune System in Health and Diseases. fifth ed. (2001), Garland Publishing, Incorporated, UK
6. Skwarlo-Sonta K., Majewski P., Markowska M., Oblap R., and Olszanska B. Bidirectional communication between the pineal gland and the immune system. Can. J. Physiol. Pharmacol. 81 (2003) 329-342
7. Dunlap J.C., Loros J.J., and DeCoursey P.J. Chronobiology: Biological Timekeeping (2004), Sinauer, Suderland, MA
8. Foster R.G., and Hankins M.W. Non-rod, non-cone photoreception in the vertebrates. Prog. Retin. Eye Res. 21 (2002) 507-527
9. Cahill G.M., and Besharse J.C. Retinal melatonin is metabolized within the eye of Xenopus laevis. Proc. Natl. Acad. Sci. USA 86 (1989) 1098-2102
10. Guido M.E., Carpentieri A.R., and Garbarino-Pico E. Circadian phototransduction and the regulation of biological rhythms. Neurochem. Res. 27 (2002) 1473-1489
11. Roberts J.E. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). J. Photochem. Photobiol. B 29 (1995) 3-15
12. Pamphilon D.H., Alnaqdy A.A., and Wallington T.B. Immunomodulation by ultraviolet light: clinical studies and biological effects. Immunol. Today 12 (1991) 119-123
13. Brainard G.C. Photic parameters that regulate the neuroendocrine system and influence behavior in humans and animals. Photodermatol. Photimmunol. Photomed. 8 (1991) 34-39
14. Carlson S.L., and Felten D. Involvement of hypothalamic and limbic structures in neural immune communication. Neuroimmune Network: Physiology and Diseases (1989), Alan Liss, New York 219-226
15. Hotchkiss A.K., and Nelson R.J. Melatonin and immune function: hype or hypothesis?. Crit. Rev. Immunol. 22 (2002) 351-371
16. Nelson R.J. Seasonal immune function and sickness responses. Trends Immunol. 25 (2004) 187-192
17. Nelson R.J., and Demas G.E. Seasonal changes in immune function. Quart. Rev. Biol. 71 (1996) 511-548
18. Rai S., and Haldar C. Pineal control of immune status and hematological changes in blood and bone marrow of male squirrels (Funambulus pennanti) during their reproductively active phase. Comp. Biochem. Physiol. (C) 136 (2003) 319-328
19. Mann D.R., Akinbami M.A., Gould K.G., and Ansari A.A. Seasonal variations in cytokine expression and cell-mediated immunity in male rhesus monkeys. Cell Immunol. 200 (2000) 105-115
20. Mann D.R., Akinbami M.A., Lunn S.F., Fraser H.M., Gould K.G., and Ansari A.A. Endocrine-immune interaction: alterations in immune function resulting from neonatal treatment with a GnRH antagonist and seasonality in male primates. Am. J. Reprod. Immunol. 44 (2000) 30-40
21. Shifrine M., Taylor N., Rosenblatt L.S., and Wilson F. Seasonal variation in cell mediated immunity of clinically normal dogs. Exp. Hematol. 8 (1980) 318-326
22. Melnikov O.F., Nikolsky I.S., Dugovskaya L.A., Balitskaya N.A., and Kravchuk G.P. Seasonal aspects of immunological reactivity of the human and animal organism. J. Hyg. Epidemiol. Microbiol. Immunol. 31 (1987) 225-230
23. Kaattari S., and Ottinger C. Seasonality of trout leukocytic sensitivity to toxicity: implications for immunotoxic biomonitoring. Mar. Environ. Res. 50 (2000) 465
24. Leonardi M.O., and Klempau A.E. Artificial photoperiod influence on the immune system of juvenile rainbow trout (Oncorhynchus mykiss) in the southern hemisphere. Aquaculture 221 (2003) 581-591
25. Haldar C., Singh R., and Guchhait P. Relationship between the annual rhythms in melatonin and immune system status in the tropical palm squirrel Funambulus pennanti. Chronobiol. Int. 18 (2001) 61-69
26. In: Nelson R.J., Demas G.E., Klein S.L., and Kriegsfeld L.J. (Eds). Seasonal Patterns of Stress, Immune Function and Disease (2002), Cambridge Univ. Press, New York
27. Nelson R.J., Demas G.E., Klein S.L., and Kriegsfeld L.J. The influence of season, photoperiod and pineal melatonin on immune function. J. Pineal Res. 19 (1995) 149-165
28. Champney T.H., and McMurray D.N. Spleen morphology and lymphoproliferative activity in short photoperiod exposed hamsters. In: Fraschini F., and Reiter R.J. (Eds). Role of Melatonin and Pineal Peptides in Neuroimmunomodulation (1991), Plenum Press, London 219-225
29. Slominski A., Fischer T.W., Zmijewski M.A., Wortsman J., Semak I., Zbytek B., Slominski R.M., and Tobin D.J. On the role of melatonin in skin physiology and pathology. Endocrine 27 (2005) 137-148
30. Weiss J.M., Renkl A.C., Denfeld R.W., de Roche R., Spitzlei M., Schopf E., and Simon J.C. Low-dose UVB radiation perturbs the functional expression of B7-1 and B7-2 co-stimulatory molecules on human Langerhans cells. Eur. J. Immunol. 25 (1995) 2858-2862
31. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
32. Ullrich S.E. Does exposure to UV radiation induce a shift to a Th-2-like immune reaction?. Photochem. Photobiol. 64 (1996) 254-258
33. Araneo B.A., Dowell T., Moon H.B., and Daynes R.A. Regulation of murine lymphocyte production in vivo. UV radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1 dependent mechanism. J. Immunol. 143 (1989) 1737-1744
34. Simon J.C., Mosmann T., Edelbaum D., Schopf E., Bergstresser P.R., and Cruz P.D. In vivo evidence that ultraviolet B-induced suppression of allergic contact sensitivity is associated with functional inactivation of Th1 cells. Photodermatol. Photoimmunol. Photomed. 10 (1994) 206-211
35. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., and Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
36. McHugh R.S., and Shevach E.M. The role of suppressor T cells in regulation of immune responses. J. Allergy Clin. Immunol. 110 (2002) 693-702
37. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., and Levings M.K. Type 1 T regulatory cells. Immunol. Rev. 182 (2001) 68-79
38. Shreedhar V.K., Pride M.W., Sun Y., Kripke M.L., and Strickland F.M. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J. Immunol. 161 (1998) 1327-1335
39. Schwarz A., Grabbe S., Grosse-Heitmeyer K., Roters B., Riemann H., Luger T.A., Trinchieri G., and Schwarz T. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J. Immunol. 160 (1998) 4262-4270
40. Simon J.C., Hara H., Denfeld R.W., and Martin S. UV-B-irradiated dendritic cells induce nonproliferating, regulatory type T cells. Skin Pharmacol. Appl. Skin Physiol. 15 (2002) 330-334
41. Schwarz A., Beissert S., Grosse-Heitmeyer K., Gunzer M., Bluestone J.A., Grabbe S., and Schwarz T. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J. Immunol. 165 (2000) 1824-1831
42. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
43. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., and Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203 (2006) 2673-2682
44. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., and Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 566-573
45. Moodycliffe A.M., Nghiem D., Clydesdale G., and Ullrich S.E. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1 (2000) 521-525
46. Noonan F.P., and Defabo E.C. Immunosupression by ultraviolet B radiation: initiation by urocanic acid. Immunol. Today 13 (1992) 250-254
47. Provencio I., Rodriguez I.R., Jiang G., Hayes W.P., Moreira E.F., and Rollag M.D. A novel human opsin in the inner retina. J. Neurosci. 20 (2000) 600-605
48. Berson D.M., Dunn F.A., and Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 295 (2002) 1070-1073
49. Skwarlo-Sonta K. Functional connection between the pineal gland and immune system. Acta Neurobiol. Exp. 56 (1996) 341-357
50. Haldar C., Singh S.S., Rai S., Skwarlo-Sonta K., Pawlak J., and Singaravel M. Melatonin and immunomodulation: involvement of the neuroendocrine network. In: Haldar C., Singaravel M., Pandi-Perumal S.R., and Cardinali D.P. (Eds). Experimental Endocrinology and Reproductive Biology (2008), Science Publisher, Enfield, NH, USA 297-314
51. Johnston J.D., Ebling F.J., and Hazlerigg D.G. Photoperiod regulates multiple gene expression in the suprachiasmatic nuclei and pars tuberalis of the Siberian hamster (Phodopus sungorus). Eur. J. Neurosci. 21 (2005) 2967-2974
52. Arendt J., and Skene D.J. Melatonin as a chronobiotic. Sleep Med. Rev. 9 (2005) 25-39
53. Arendt J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev. Reprod. 3 (1998) 13-22
54. Grossman C.J. Regulation of the immune system by sex steroids. Endocr. Rev. 5 (1984) 435-455
55. Demas G.E., and Nelson R.J. Short-day enhancement of immune function is independent of steroid hormones in deer mice (Peromyscus maniculatus). J. Comp. Physiol. [B] 168 (1998) 419-426
56. Blom J.M., and Gerber R.J. Nelson, Day length affects immune cell numbers in deer mice: interactions with age, sex, and prenatal photoperiod. Am. J. Physiol. 267 (1994) R596-R601
57. Demas G.E., and Nelson R.J. Photoperiod, ambient temperature, and food availability interact to affect reproductive and immune function in adult male deer mice (Peromyscus maniculatus). J. Biol. Rhythms 13 (1998) 253-262
58. Demas G.E., and Nelson R.J. Photoperiod and temperature interact to affect immune parameters in adult male deer mice (Peromyscus maniculatus). J. Biol. Rhythms 11 (1996) 94-102
59. Lochmiller R., and Deerenberg C. Trade-offs in evolutionary immunology: just what is the cost of immunity?. Oikos 88 (2000) 87-98
60. Levi F., Canon C., Diplama N., Florentin I., and Misset J.L. When should be the immune clock be reset?. Ann. NY. Acad. Sci. 618 (1991) 312-339
61. Maestroni G.J.M., Hertens E., and Galli P. Melatonin induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin. J. Pineal Res. 21 (1996) 131-139
62. Szczepanik M. Melatonin and its influence on immune system. J. Physiol. Pharmacol. 58 (2007) 115-124
63. Esquifino A.I., Pandi-Perumal S.R., and Cardinali D.P. Circadian organization of the immune response: a role for melatonin. Clin. Appl. Immunol. Rev. 4 (2004) 423-433
64. Guerrero J.M., and Reiter R.J. Melatonin-immune system relationships. Curr. Top. Med. Chem. 2 (2002) 167-179
65. Maestroni G.J. The immunotherapeutic potential of melatonin. Expert Opin. Investig. Drugs 10 (2001) 467-476
66. Srinivasan V., Maestroni G.J., Cardinali D.P., Esquifino A.I., Perumal S.R., and Miller S.C. Melatonin, immune function and aging. Immun. Ageing 29 (2005) 2-17
67. Moore C.B., Siopes T.D., Steele C.T., and Underwood H. Pineal melatonin secretion, but not ocular melatonin secretion, is sufficient to maintain normal immune responses in Japanese quail (Coturnix coturnix japonica). Gen. Comp. Endocrinol. 126 (2002) 352-358
68. Maestroni G.J., Conti A., and Pierpaoli W. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J. Neuroimmunol. 13 (1986) 19-30
69. Maestroni G.J., Conti A., and Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Ann. NY. Acad. Sci. 496 (1987) 67-77
70. Prendergast B.J., Yellon S.M., Tran L.T., and Nelson R.J. Photoperiod modulates the inhibitory effect of in vitro melatonin on lymphocyte proliferation in female Siberian hamsters. J. Biol. Rhythms 16 (2001) 224-233
71. Markowska M., Mrozkowiak A., and Skwarlo-Sonta K. Influence of melatonin on chicken lymphocytes in vitro: involvement of membrane receptors. Neuroendocrinol. Lett. 23 (2002) 67-72
72. Peters B.A., Sothmann M., and Wehrenberg W.B. Blood leukocyte and spleen lymphocyte immune responses in chronically physically active and sedentary hamsters. Life Sci. 45 (1989) 2239-2245
73. Kuhlwein E., and Irwin M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J. Neuroimmunol. 117 (2001) 51-57
74. Garcia-Maurino S., Pozo D., Carrillo-Vico A., Calvo J.R., and Guerrero J.M. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 65 (1999) 2143-2150
75. Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R., Rafii-el-Idrissi M., Sanchez-Margalet V., Goberna R., and Guerrero J.M. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 159 (1997) 574-581
76. Morrey K.M., McLachlan J.A., Serkin C.D., and Bakouche O. Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 153 (1994) 2671-2680
77. Barjavel M.J., Mamdouh Z., Raghbate N., and Bakouche O. Differential expression of the melatonin receptor in human monocytes. J. Immunol. 160 (1998) 1191-1197
78. Carrillo-Vico A., Calvo J.R., Abreu P., Lardone P.J., Garcia-Maurino S., Reiter R.J., and Guerrero J.M. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J. 18 (2004) 537-539
79. Liu F., Ng T.B., and Fung M.C. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J. Neural. Transm. 108 (2001) 397-405
80. Cardinali D.P. Melatonin. Physiology and clinical applications. Vertex 18 July-August (2007) 288-293
81. Molpeceres V., Mauriz J.L., García-Mediavilla M.V., Gonzalez P., Barrio J.P., and Gonzalez-Gallego J. Melatonin is able to reduce the apoptotic liver changes induced by aging via inhibition of the intrinsic pathway of apoptosis. J. Gerontol. A. Biol. Sci. Med. Sci. 62 (2007) 687-695
82. Radogna F., Paternoster L., Albertini M.C., Accorsi A., Cerella C., D'Alessio M., De Nicola M., Nuccitelli S., Magrini A., Bergamaschi A., and Ghibelli L. Melatonin as an apoptosis antagonist. Ann. NY. Acad. Sci. 1090 (2006) 226-233
83. Fulop Jr T., Foris G., Worum I., Paragh G., and Leovey A. Age related variations of some polymorphonuclear leukocyte functions. Mech. Ageing Dev. 29 (1985) 1-8
84. Ginaldi L., Loreto M.F., Corsi M.P., Modesti M., and De Martinis M. Immunosenescence and infectious diseases. Microbes Infect. 3 (2001) 851-857
85. Dori D., Casale G., Solerte S.B., Fioravanti M., Migliorati G., Cuzzoni G., and Ferrari E. Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiologia 21 (1994) 121-126
86. Girotti L., Lago M., Ianovsky O., Carbajales J., Elizari M.V., Brusco L.I., and Cardinali D.P. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J. Pineal Res. 29 (2000) 138-142
87. Luboshitzky R., Shen-Orr Z., Tzischichinsky O., Maldonado M., Herer P., and Lavie P. Actigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer's disease. Chronobiol. Int. 18 (2001) 513-524
88. Fulop Jr. T., Wagner J.R., Khalil A., Weber J., Trottier L., and Payette H. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J. Gerontol. A. Biol. Sci. Med. Sci. 54 (1999) M59-M64
89. Constantinescu C.S., Hillard B., and Ventura E. Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis. Pathobiology 65 (1997) 190-194
90. Hansson I., Holmdahl R., and Mattsson R. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J. Neuroimmunol. 39 (1992) 23-30
91. Shaji A.V., Kulkarni S.K., and Agrewala J.N. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin-specific T cells. Clin. Exp. Immunol. 111 (1998) 181-185
92. Escames G., Acuna-Castroviejo D., Lopez L.C., Tan D.X., Maldonado M.D., Sanchez-Hidalgo M., Leon J., and Reiter R. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J. Pharm. Pharmacol. 58 (2006) 1153-1165
93. Nosal'ova V., Zeman M., Cerna S., Navarova J., and Zakalova M. Protective effect of melatonin in acetic acid induced colitis in rats. J. Pineal Res. 42 (2007) 364-370
94. Jaworek J., Konturek S.J., Tomaszewska R., Leja-Szpak A., Bonior J., Nawrot K., Palonek M., Stachura J., and Pawlik W.W. The circadian rhythm of melatonin modulates the severity of caerulein-induced pancreatitis in the rat. J. Pineal Res. 37 (2004) 161-170
95. Leja-Szpak A., Jaworek J., Nawrot-Porabka K., Palonek M., Mitis-Musiol M., Dembinski A., Konturek S.J., and Pawlik W.W. Modulation of pancreatic enzyme secretion by melatonin and its precursor; l-tryptophan. Role of CCK and afferent nerves. J. Physiol. Pharmacol. 55 (2004) 33-46
96. Chuang J.I., Mohan N., Meltz M.L., and Reiter R.J. Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol. Int. 20 (1996) 687-692
97. Bertuglia S., Marchiafava P.L., and Colantuoni A. Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc. Res. 31 (1996) 947-952
98. Sewerynek E., Reiter R.J., Melchiorri D., Ortiz G.G., and Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 43 (1996) 898-905
99. Reiter R.J., Calvo J.R., Karbownik M., Qi W., and Tan D.X. Melatonin and its relation to the immune system and inflammation. Ann. NY. Acad. Sci. 917 (2000) 376-386
100. d'Emmanuele di Villa Bianca R., Marzocco S., Di Paola R., Autore G., Pinto A., Cuzzocrea S., and Sorrentino R. Melatonin prevents lipopolysaccharide-induced hyporeactivity in rat. J. Pineal Res. 36 (2004) 146-154
101. Gilad E., Wong H.R., Zingarelli B., Virag L., O'Connor M., Salzman A.L., and Szabo C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J. 12 (1998) 685-693
102. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63-78
103. Maestroni G.J. Melatonin as a therapeutic agent in experimental endotoxic shock. J. Pineal Res. 20 (1996) 84-89
104. Requintina P.J., and Oxenkrug G.F. Differential effects of lipopolysaccharide on lipid peroxidation in F344N, SHR rats and BALB/c mice, and protection of melatonin and NAS against its toxicity. Ann. NY. Acad. Sci. 993 (2003) 325-333
105. Wu C.C., Chiao C.W., Hsiao G., Chen A., and Yen M.H. Melatonin prevents endotoxin-induced circulatory failure in rats. J. Pineal Res. 30 (2001) 147-156
106. Sullivan D.J., Shelby J., Shao Y., Affleck D.G., Hinson D.M., and Barton R.G. Melatonin and a 21-aminosteroid attenuate shock after hemorrhage but differentially affect serum cytokines. J. Surg. Res. 64 (1996) 13-18
107. Armstrong S.M., and Redman J.R. Melatonin: a chronobiotic with anti-aging properties?. Med. Hypotheses 34 (1991) 300-309
108. Sutherland E.R., Martin R.J., Ellison M.C., and Kraft M. Immunomodulatory effects of melatonin in asthma. Am. J. Respir. Crit. Care Med. 166 (2002) 1055-1061
109. Chen Q., and Wei W. Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat. Int. Immunopharmacol. 2 (2002) 443-1449
110. Moore C.B., and Siopes T.D. Melatonin can produce immunoenhancement in Japanese quail (Coturnix coturnix japonica) without prior immunosuppression. Gen. Comp. Endocrinol. 129 (2002) 122-126
111. Meyer P., Pache M., Loeffler Ku., Brydon L., Jockers R., Flammer J., Wirz-Justice A., and Savaskan E. Melatonin MT-1-receptor immunoreactivity in the human eye. Br. J. Ophthalmol. 86 (2002) 1053-1057
112. Molinero P., Soutto M., Benot S., Hmadcha A., and Guerrero J.M. Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin alpha1 and thymulin concentrations: observations in rats and humans. J. Neuroimmunol. 103 (2000) 180-188
113. Karasek M., and Fraschini F. Is there a role for the pineal gland in neoplastic growth?. In: Fraschini F., and Reiter R.J. (Eds). Role of Melatonin and Pineal Peptides in Neuroimmunomodulation (1991), Plenum, New York, NY 243-251
114. Coleman M.P., and Reiter R.J. Breast cancer, blindness and melatonin. Eur. J. Cancer. Clin. Oncol. 28 (1992) 501-503
115. Bartsch C., Bartsch H., Fluchter St H., and Lippert T.H. Depleted pineal melatonin production in primary breast and prostate cancer is connected with circadian disturbances: possible role of melatonin for synchronization of circadian rhythmicity. In: Touitou Y., Arendt J., and Pevet P. (Eds). Melatonin and the Pineal Gland - From Basic Science to Clinical Application (1993), Elsevier, New York, NY 311-316
116. Bartsch C., Bartsch H., Jain A.K., Laumas K.R., and Wetterberg L. Urinary melatonin levels in breast cancer patients. J. Neural Transm. 52 (1981) 281-294
117. Maestroni G.J.M., and Conti A. Melatonin and the immune system. In: Touitou Y., Arendt J., and Pevet P. (Eds). Melatonin and the Pineal Gland - From Basic Science to Clinical Application (1993), Elsevier, New York, NY 295-302
118. Maestroni G.J.M., Conti A., and Pierpaoli W. Role of the pineal gland in immunity: circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J. Neuroimmunol. 13 (1986) 19-30
119. Mori W., Aoyama H., and Mori N. Melatonin protects rats from injurious effects of a glucocorticoid, dexamethasone. Jpn. J. Exp. Med. 54 (1984) 255-261
120. Sorenson D. An adventitious role of cortisol in degenerative processes due to decreased opposition by insulin: implications for aging. Med. Hypotheses 7 (1981) 315-331
121. Maestroni G.J.M., and Conti A. Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin. Int. J. Immunopharmacol. 11 (1989) 333-340
122. Paparrigopoulos T. Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression. Acta Psychiatr. Scand. 106 (2002) 440-445
123. 3: a biological phase-II study. J. Biol. Reg. Homeos. Agents 9 (1995) 155-158
124. Dubocovich M.L. Melatonin receptors: are there multiple subtypes?. Trends Pharmacol. Sci. 16 (1995) 50-56
125. Reppert S.M., Weaver D.R., and Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13 (1994) 1177-1185
126. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., and Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel 1b melatonin receptor. Proc. Natl. Acad. Sci. USA 92 (1995) 8734-8738
127. 2 melatonin receptors in mammals. Endocrine 27 (2005) 101-110
128. 3 as the quinone reductase 2. J. Biol. Chem. 275 (2000) 31311-31317
129. Becker-Andre M., Wiesenberg I., Schaeren-Wiemers N., Andre E., Missbach M., Saurat J.H., and Carlberg C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269 (1994) 28531-28534
130. Becker-Andre M., Andre E., and DeLamarter J.F. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem. Biophys. Res. Commun. 194 (1993) 1371-1379
131. Wiesenberg I., Missbach M., and Carlberg C. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor. Neurol. Neurosci. 12 (1998) 143-150
132. Carlberg C. Gene regulation by melatonin. Ann. NY. Acad. Sci. 917 (2000) 387-396
133. Benitez-King G., and Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 49 (1993) 635-641
134. Macias M., Escames G., Leon J., Coto A., Sbihi Y., Osuna A., and Acuna-Castroviejo D. Calreticulin-melatonin. An unexpected relationship. Euro. J. Biochem. 270 (2003) 832-840
135. Cardinali D.P., and Freire F. Melatonin effects on brain. Interaction with microtubule protein, inhibition of fast axoplasmic flow and induction of crystaloid and tubular formations in the hypothalamus. Mol. Cell. Endocrinol. 2 (1975) 317-330
136. Melendez J., Maldonado V., and Ortega A. Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. Neurochem. Res. 21 (1996) 653-658
137. Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J. Pineal Res. 40 (2006) 1-9
138. Benitez-King G., Huerto-Delgadillo L., and Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci. 53 (1993) 201-207
139. 2+/calmodulin-dependent kinase II activity by melatonin. Biochim. Biophys. 1290 (1996) 191-196
140. Hardeland R. New actions of melatonin and their relevance to biometeorology. Int. J. Biometeorol. 41 (1997) 47-57
141. Soto-Vega E., Meza I., Ramrez-Rodrguez G., and Benitez-King G. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J. Pineal Res. 37 (2004) 98-106
142. Hardeland R., and Fuhrberg B. Ubiquitous melatonin - presence and effects in unicells, plants and animals. Trends Comp. Biochem. Physiol. 2 (1996) 25-45
143. Poon A.M., and Pang S.F. 2[125I] iodomelatonin binding sites in spleens of guinea pigs. Life Sci. 50 (1992) 1719-1726
144. Poon A.M., and Pang S.F. Modulation of 2[125I] iodomelatonin binding sites in the guinea pig spleen by melatonin injection is dependent on the dose and period but not the time. Life Sci. 54 (1994) 1441-1448
145. Lopez-Gonzalez A.M., Martin-Cacao A., Calvo J.R., Reiter R.J., Osuna C., and Guerrero J.M. Specific binding of 2-[125I]melatonin by partially purified membranes of rat thymus. J. Neuroimmunol. 45 (1993) 121-126
146. Martin-Cacao A., Lopez-Gonzalez M.A., Reiter R.J., Calvo J.R., and Guerrero J.M. Binding of 2-[125I]melatonin by rat thymus membranes during postnatal development. Immunol. Lett. 36 (1993) 59-63
147. Garcia-Perganeda A., Guerrero J.M., Rafii-El-Idrissi M., Paz Romero M., Pozo D., and Calvo J.R. Characterization of membrane melatonin receptor in mouse peritoneal macrophages: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein. J. Neuroimmunol. 95 (1999) 85-94
148. Garcia-Perganeda A., Pozo D., Guerrero J.M., and Calvo J.R. Signal transduction for melatonin in human lymphocytes: involvement of a pertussis toxin-sensitive G protein. J. Immunol. 159 (1997) 3774-3781
149. 125 I]iodomelatonin binding sites in the thymus of mice and its significance. Sci. China B 38 (1995) 1455-1461
150. Rafii-El-Idrissi M., Calvo J.R., Harmouch A., Garcia-Maurino S., and Guerrero J.M. Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat. J. Neuroimmunol. 86 (1998) 190-197
151. Pozo D., Delgado M., Fernandez-Santos J.M., Calvo J.R., Gomariz R.P., Martin-Lacave I., Ortiz G.G., and Guerrero J.M. Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J. 11 (1997) 466-473
152. Garcia-Maurino S., Pozo D., Calvo J.R., and Guerrero J.M. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J. Pineal Res. 29 (2000) 129-137
153. Carrillo-Vico A., Garcia-Maurino S., Calvo J.R., and Guerrero J.M. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1membrane receptor. FASEB J. 17 (2003) 755-757
154. Pozo D., Garcia-Maurino S., Guerrero J.M., and Calvo J.R. mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT, and hydroxindole-O-methyltransferase in different populations of human immune cells. J. Pineal Res. 37 (2004) 48-54
155. Dubocovich M.L., Rivera-Bermudez M.A., Gerdin M.J., and Masana M.I. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front. Biosci. 8 (2003) d1093-d1108
156. Drazen D.L., Bilu D., Bilbo S.D., and Nelson R.J. Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1476-1482
157. Drazen D.L., and Nelson R.J. Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology 74 (2001) 178-184
158. Wiesenberg I., Missbach M., Kahlen J.P., Schrader M., and Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23 (1995) 327-333
159. Pozo D., Reiter R.J., Calvo J.R., and Guerrero J.M. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem. 65 (1997) 430-442
160. Romero M.P., Garcia-Perganeda A., Guerrero J.M., and Osuna C. Membrane-bound calmodulin in Xenopus laevis oocytes as a novel binding site for melatonin. FASEB J. 12 (1998) 1401-1408
161. Reiter R.J. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front. Neuroendocrinol. 16 (1995) 383-415
162. Depreux P., Lesieur D., Mansour H.A., Morgan P., Howell H.E., Renard P., Caignard D.H., Pfeiffer B., Delagrange P., and Guardiola B. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. J. Med. Chem. 37 (1994) 3231-3239
163. Carrillo-Vico A., Garcia-Perganeda A., Naji L., Calvo J.R., Romero M.P., and Guerrero J.M. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell. Mol. Life Sci. 60 (2003) 2272-2278
164. Drazen D.L., and Nelson R.J. Melatonin receptor subtype MT2 (Mel 1b) and Not mt 1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology 74 (2001) 178-184
165. Castrillon P., Cardinali D.P., Pazo D., Cutrera R.A., and Esquifino A.I. Effect of superior cervical ganglionectomy on 24-h variations in hormone secretion from anterior hypophysis and in hypothalamic monoamine turnover, during the preclinical phase of Freund's adjuvant arthritis in rats. J. Neuroendocrinol. 13 (2001) 288-295
166. Yu Q., Miller S.C., and Osmond D.G. Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J. Pineal Res. 29 (2000) 86-93
167. Missbach M., Jagher B., Sigg I., Nayeri S., Carlberg C., and Wiesenberg I. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity. J. Biol. Chem. 271 (1996) 13515-13522
168. Smirnov A.N. Nuclear melatonin receptors. Biochemistry (Mosc) 66 (2001) 19-26
169. Reiter R.J., Tan D.X., Gitto E., Sainz R.M., Mayo J.C., Leon J., Manchester L.C., Vijayalaxmi, Kilic E., and Kilic U. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol. J. Pharmacol. 56 (2004) 159-170
170. Cardinali D.P., Golombek D.A., Rosenstein R.E., Cutrera R.A., and Esquifino A.I. Melatonin site and mechanism of action: single or multiple?. J. Pineal Res. 3 (1997) 32-39
171. Brusco L.I., Garcia-Bonacho M., Esquifino A.I., and Cardinali D.P. Diurnal rhythms in norepinephrine and acetylcholine synthesis of sympathetic ganglia, heart and adrenals of aging rats: effect of melatonin. J. Auton. Nerv. Syst. 74 (1998) 49-61